BGR GOVERNMENT AFFAIRS for ROIVANT SCIENCES, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advise client on legislative and administrative policy-making related to the biopharmaceutical industry generally, and client priorities specifically. Includes raising awareness amongst public officials about the importance of addressing disease areas of high unmet medical need where client and its affiliates are working to develop new medicines.
Foreign entity interest: Roivant Sciences Ltd. 100% Roivant Sciences Holdings Ltd. 100% Roivant Sciences GmbH 0% Axovant Sciences Ltd 0% Axovant Sciences GmbH 0%
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER | See prior filing |
| BRENT ALAN DEL MONTE | See prior filing |
| RYAN LONG | See prior filing |
| ROBB WALTON | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.